Veltek Associates, Inc.

home / authors / veltek-associates-inc-10

Articles

Accelerating Biopharma Development and Manufacturing through CDMOs and CGT

Jubilant;Ligand;Thermo Fisher Applied Biosystems;Experic;Catalent;Veltek Associates, Inc.

June 28th 2023

Webinar Date/Time: Thu, Jul 20, 2023 11:00 AM EDT

Cart2Core™- Aseptic Cart Transferring System

Veltek Associates, Inc.

February 14th 2019

VAI’s Cart2Core®, a patent pending technology, virtually eliminates the problematic issue of correct aseptic cart transference by making the cart top transferable to a new base at each new classification.

Latest Updated Articles

3d rendering of Antibody drug conjugates (ADCs) are targeted medicines that deliver chemotherapy agents to cancer cells | Image Credit: © Love Employee - © Love Employee- stock.adobe.com

Published: February 4th 2025 | Updated: March 3rd 2025

Advancing ADCs to the Next Level

Published: October 10th 2024 | Updated: March 3rd 2025

CPHI Milan 2024: New Developments in ADC Technologies

TOP NEWS on grunge world map | Image Credit: © Sean K - © Sean K - stock.adobe.com

Published: January 10th 2025 | Updated: January 13th 2025

Cavazzoni Retires as CDER Director

Published: October 11th 2024 | Updated: October 18th 2024

Buy, Sell, Hold: Cell and Gene Therapy - Part 1

Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - © Artur - stock.adobe.com

Published: September 10th 2024 | Updated: September 18th 2024

CPHI Milan Announces 2024 CPHI Pharma Award Finalists

Published: February 28th 2025 | Updated: March 3rd 2025

EMA Recommends Four Medicines for Approval in February

About Us

Advertise

Editorial Info

Editorial Advisory Board

Do Not Sell My Personal Information

Terms and Conditions

Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777